tiprankstipranks
10x Genomics Inc (TXG)
NASDAQ:TXG
Holding TXG?
Track your performance easily

10x Genomics (TXG) Financial Statements

882 Followers

10x Genomics Financial Overview

10x Genomics's market cap is currently ―. The company's EPS TTM is $-2.02; its P/E ratio is -11.23; 10x Genomics is scheduled to report earnings on October 30, 2024, and the estimated EPS forecast is $-0.33. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 153.10M$ 141.01M$ 183.98M$ 153.64M$ 146.82M
Gross Profit$ 104.22M$ 92.91M$ 115.78M$ 95.53M$ 146.82M
EBIT$ -37.08M$ -57.80M$ -46.59M$ -91.74M$ -60.76M
EBITDA$ -26.18M$ -46.31M$ -34.88M$ -80.32M$ -48.88M
Net Income Common Stockholders$ -37.90M$ -59.95M$ -48.95M$ -10.18M$ -62.41M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 380.09M$ 371.81M$ 388.69M$ 356.91M$ 392.88M
Total Assets$ 929.67M$ 922.91M$ 965.14M$ 948.54M$ 989.64M
Total Debt$ 89.48M$ 92.18M$ 95.37M$ 98.47M$ 99.62M
Net Debt$ -290.61M$ -279.64M$ -293.32M$ -258.43M$ -293.27M
Total Liabilities$ 205.61M$ 204.08M$ 224.10M$ 203.32M$ 196.34M
Stockholders Equity$ 724.06M$ 718.83M$ 741.04M$ 745.22M$ 793.30M
Cash Flow-
Free Cash Flow$ 3.62M$ -18.64M$ 22.31M$ -40.76M$ -36.87M
Operating Cash Flow$ 7.50M$ -15.72M$ 25.76M$ -25.32M$ -11.51M
Investing Cash Flow$ 11.95M$ 10.63M$ 13.10M$ 4.90M$ -4.46M
Financing Cash Flow$ 4.60M$ 1.64M$ 5.61M$ 4.37M$ 7.10M
Currency in USD

10x Genomics Earnings and Revenue History

10x Genomics Debt to Assets

10x Genomics Cash Flow

10x Genomics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis